Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. [PDF]
Yosipovitch G +8 more
europepmc +1 more source
IL31 identified as a key genetic risk factor for prurigo nodularis. [PDF]
Patrick MT +7 more
europepmc +1 more source
Pregabalin as a Potential Adjunct in the Management of Pruritus in Prurigo Nodularis: A Case Report. [PDF]
Mima Y, Yamamoto M, Iozumi K.
europepmc +1 more source
Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies. [PDF]
Kwatra SG +9 more
europepmc +1 more source
Prurigo Nodularis Increases Risk of Non-alcoholic Fatty Liver Disease and Liver Cirrhosis: A Global-federated Retrospective Cohort Study. [PDF]
Chang HC +8 more
europepmc +1 more source
Dupilumab treatment for prurigo nodularis: a retrospective study of 76 patients. [PDF]
Zhao Y, Gao C, Leng H.
europepmc +1 more source
Dupilumab: an Additional Arrow in the Quiver for Prurigo Nodularis? Data From a Real-Life Setting. [PDF]
Di Caprio R +6 more
europepmc +1 more source

